How to Buy Vyne Therapeutics Stock

Vyne Therapeutics Inc

VYNE Therapeutics Inc. , a pharmaceutical company, focuses on developing various therapeutics for the treatment of immuno-inflammatory conditions.

Vyne Therapeutics stock last closed at $0.37, up 5.48% from the previous day, and has decreased 86.59% in one year. It has underperformed other stocks in the Biotechnology industry by 0.63 percentage points. Vyne Therapeutics stock is currently +30.25% from its 52-week low of $0.28, and -91.49% from its 52-week high of $4.30.

As of Oct 30, 2025, there are 25.47M shares of VYNE outstanding. The market cap of VYNE is $9.32M. In the past 24 hours, 5.14M VYNE shares were traded.

How to Buy Vyne Therapeutics Stock

Wondering how to invest in Vyne Therapeutics stock? Here's how.

  1. Decide where to buy Vyne Therapeutics stock: You need to pick an online brokerage, but don't worry - we've sifted through dozens of online stock brokerages and apps to help you figure out where to buy Vyne Therapeutics stock.
  2. Open a brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've identified.
  3. Put funds into your investment account: Choose your payment method and add your details.
  4. Research Vyne Therapeutics stock: The Vyne Therapeutics ticker symbol is VYNE. Is Vyne Therapeutics stock a good investment? Should you buy shares of VYNE? How do VYNE's underlying business fundamentals look? Do top analysts think Vyne Therapeutics is a good buy? Why has VYNE's stock price moved recently? (Hint: Our stock research website can help you evaluate if VYNE is a good stock to buy).
  5. Execute your VYNE trade: Decide if you will purchase VYNE shares at the current market price or use a limit order to purchase VYNE shares at a given price.
  6. Get notifications regarding your VYNE position: Create a watchlist to key updates about your new investment in Vyne Therapeutics shares.

Step 1: Decide where to buy Vyne Therapeutics stock

You need an online brokerage account in order to access the NASDAQ market and buy VYNE stock.

A brokerage account is an investment account that enables you to buy and sell a number of financial instruments, such as stocks, bonds, mutual funds, and ETFs.

Our preferred brokerage: eToro

Based on our experience, eToro is the best brokerage. Here's why:

  • Invest in stocks with 0% commissions: Invest without commissions.
  • Buy fractional shares: Even if you can't afford a full share, you can still invest in the stock.
  • Access to global markets: From Tech to Healthcare, New York to London (for US users, only US stocks are available) — you can fill your portfolio with stocks from the globe's leading stock exchanges.
  • Social investing: eToro has a community with more than 20 million users around the world. Talk to, learn from, and copy the crypto trades of other investors.
  • Security: eToro is a regulated and licensed fintech leader.
  • Buy other financial assets: Such as ETFs and cryptocurrencies.

Get $10 towards your purchase of shares by signing up for an account with eToro now. This offer is only for US users.

Open eToro Account
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.

Step 2: Open a brokerage account

Now that you've picked the right brokerage, the next step is to fill out some personal information so you can invest in VYNE stock today.

How to Open a New Investment Account on eToro

  1. Click here to get started.
    eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
  2. Input your personal info to open a new brokerage account.
  1. Send your application by pressing the "Create Account" button.
  2. Get started with eToro today
    eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Step 3: Put funds into your investment account

Now that you have finished signing up on one of the most highly reviewed stock market apps, you can securely and quickly fund your account:

Check out this video walkthrough to see the process of transferring money into your new brokerage account.

Get started with eToro today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Step 4: Research Vyne Therapeutics stock

Once you have selected the best place to buy Vyne Therapeutics stock, it's absolutely critical to evaluate their stock before you invest, so you actually understand the risk as well as the opportunity.

Vyne Therapeutics Metrics

VYNE Price
$0.37
1w %
-1.08%
1y %
-86.59%
5y %
-99.68%
P/E
-0.41x
P/B
0.24x
P/S
33.27x
PEG
N/A
Revenue
$476.00k
Earnings
-$38.55M
Fore. Rev. Growth
-65%
Fore. Earn. Growth
N/A
Market Cap
$9.32M
Next Earnings
N/A
Next Dividend
N/A

Vyne Therapeutics Due Diligence Score

WallStreetZen was built to help everyday investors do better fundamental analysis in minutes instead of hours.

You can view all of the due diligence checks on VYNE's stock page.

How is VYNE stock valued?

You can use many financial metrics, analyses, models, and charts to gauge VYNE's intrinsic value.

Using relative valuations ratios:

  • VYNE could be undervalued based on its P/B ratio of 0.24x, relative to Biotechnology industry P/B ratio of 4.97x

You can do more valuation analysis on VYNE's stock here.

How do VYNE Financials look?

Passed Health Checks:

  • VYNE has $39.65M in cash and short term investments. This is enough to cover its annual cash burn of $39.89M.
  • There are more short-term assets than long-term liabilities on the VYNE balance sheet.
  • VYNE has a low debt to equity ratio of 0.15.
  • Total VYNE debt is lower than 5 years ago, relative to shareholder equity.
  • There are more short-term assets than short-term liabilities on the VYNE balance sheet.

Failed Health Checks:

  • VYNE has cash burn of 39890000. It does not have sufficient cash and short-term investments to cover this.
  • VYNE profit margin has gone down from -5,849.2% to -8,097.7% in the past year.

You can dig deeper into what analysts are projecting on the Vyne Therapeutics stock forecast page.

VYNE Technical Indicators

SMA10
0.36
SMA20
0.37
SMA50
0.34
SMA100
0.65
SMA200
1.25
MACD
0
MACD Signal
0
MACD Histogram
0
RSI
49.99
Stochastic %K
27.63
Stochastic %D
22.85
StochRSI %K
19.64
StochRSI %D
13.62

VYNE Performance Metrics

Last year, VYNE revenue was $476.00k. In the last five year, VYNE's revenue has gone up by -48.83% per year. This was slower than the Biotechnology industry average of 70.04%.

You can analyze VYNE's earnings and revenue performance here.

What are VYNE executives and large shareholders up to?

In the past 12 months, executives and large shareholders at VYNE have sold more shares than they have bought.

David Domzalski, PRESIDENT AND CEO of VYNE, was the latest VYNE insider to sell. They sold $4,246.46 worth of VYNE shares on Sep 30, 2025.

Dig into more about who owns VYNE stock here.

Can I get consistent income from VYNE stock?

No, Vyne Therapeutics doesn't provide an income stream by paying out dividends.

Get opinions from other investors

One of the major reasons eToro is our top-rated brokerage is because of its social trading community.

Click below to find out what other investors have to say.

Step 5: Execute your VYNE trade

You have two main options:

  • Market order: A market order is an order to buy or sell a security at the best available price.
    Market orders are usually sufficient.
  • Limit order: A limit order allows you to buy or sell a security at a specific price (or better).
    If you want to make sure you're buying or selling at a particular dollar amount, use a limit order.

Hit the Open button and eToro will execute your order.

If you require more assistance investing in stocks on eToro, watch the how to video below:

Open eToro Account

Step 6: Get notifications regarding your VYNE position

Now that you own some shares in VYNE, you'll want to keep up with your stock purchase.

Start a watchlist to get alerted to the latest events about your VYNE stock.

VYNE Feed

How to Buy Stock in Vyne Therapeutics

To reiterate, here are the 6 steps to buy stock in Vyne Therapeutics:

  1. Decide where to buy Vyne Therapeutics stock
  2. Open a brokerage account
  3. Put funds into your investment account
  4. Research Vyne Therapeutics stock
  5. Execute your VYNE trade
  6. Get notifications regarding your VYNE position

If you are looking for a place to buy stocks, eToro is our recommended option.

Get Started with eToro Today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

If you would like to get the latest scoop on your new investment in Vyne Therapeutics, add VYNE to your watchlist below.

NASDAQ: VYNE
$0.37+0.02 (+5.48%)
Updated Oct 30, 2025
Open eToro Account
Your capital is at risk.
NASDAQ: VYNE
$0.37+0.02 (+5.48%)
Updated Oct 30, 2025
Open eToro Account
Your capital is at risk.

FAQ

How much does it cost to buy one Vyne Therapeutics share?

As of Oct 30, 2025, it costs $0.37 to buy one share of Vyne Therapeutics stock.

Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $0.18, you can buy 0.5 shares of VYNE.

Get Started with eToro Today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

What is the best way to buy Vyne Therapeutics stock?

One way to place an order for Vyne Therapeutics stock is with a brokerage account.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.